Welcome to CMAX Clinical Research

Thinking about participating in a trial?

Established in 1993 CMAX is one of Australia’s largest and most experienced clinical trial centres. Our expert team is committed to supporting innovative medical research in partnership with our national and international sponsors.

Centrally positioned in Adelaide, CMAX is located adjacent to The Royal Adelaide Hospital in South Australia's innovative Bio-Med City precinct.

RECENT ANNOUCEMENTS

We are pleased to announce the launch of Fusion Clinical Research. A new business that works with Contract Research Organisations (CROs), Sponsors and a network of General Practitioners (GPs) to provide medical trials in a community setting. We invite you to visit the new Fusion Clinical Research website and to share this wonderful new initiative with your contacts.

CMAX supports the #dontwaitmate campaign by the CCC (Continuity of Care Collaboration).

Learn more about their campaign here.

We are excited to announce an increase in our bed capacity to 66 inpatient beds.

participants

Clinical trials undertaken at CMAX have resulted in the advancement of global medicines and technologies, from cancer treatments to early warning bio-devices and hormone replacement therapies.

Sponsors

For more than two decades we have delivered early-phase clinical trials in partnership with pharmaceutical, biotechnology and device companies. We deliver to an exceptional standard, meeting all of the national and international regulatory requirements.

About

CMAX is Australia’s longest established, independent facility for clinical trials and delivers exceptional quality.

Our new, custom-built facility opened in 2016 opposite the Royal Adelaide Hospital and adjacent to Adelaide’s Bio-Med City, one of the largest health and life sciences clusters in the southern hemisphere, providing ready access to state-of-the-art facilities and equipment and world-class medical and pharmacology specialists.

Since 1993 we have delivered more than 600 early phase clinical trials, including more than 100 first time in human studies for our national and international clients which include pharmaceutical, biotechnology and device companies.

Our latest Trials

CM5221

New
Healthy Participants 21 nights in house + 1 follow up visit + 1 phone call
Study Focus:
Thyroid Cancer
Administration:
Oral Capsules
Eligibility Requirements:
  • Males and females aged 18 to 55 years
  • Females must be of non-childbearing potential (postmenopausal or surgically sterile)
  • BMI must be between 18.5 to 30kg/m²
  • Must be in good general health
  • Must not be taking any medications
  • No significant allergies
  • No blood donation 2 months prior
  • Non-smokers
Read More

CM4721

Healthy Participants 21 nights in-house + 1 visit
Study Focus:
Inflammatory Diseases
Administration:
Oral Tablet
Eligibility Requirements:
  • Males and females aged 18 to 45 years
  • BMI must be between 19 to 30kg/m²
  • Must be in good general health
  • Must not be taking any medications
  • No blood donation 2 months prior
  • No significant allergies
  • Non-Smokers
  • No dietary requirements
Read More

CM5421

New
Healthy Participants 7 nights in-house + 1 additional night
Study Focus:
Dementia
Administration:
Oral Solution
Eligibility Requirements:
  • Males and females aged 18 to 65 years
  • BMI must be between 18 to 32kg/m²
  • Body weight must be above 45kg
  • Must be in good general health
  • Must not be taking any medications (other than contraception)
  • No significant allergies
  • Light smokers allowed
Read More